RYTHM Reports $23.9 Million in Q3 Revenue and $5.9 Million Adjusted EBITDA

RYTHM reported Q3 2026 revenue of $23.9M, up 4% from the prior quarter, with adjusted EBITDA of $5.9M. Net loss was $0.5M, and cash totaled $48.2M. THC beverage depletions rose 15% sequentially and 185% year over year, reaching 320,000 cases annually. The company expanded its THC beverage portfolio and partnered with various events and venues. Due to upcoming restrictions, RYTHM withheld its Q4 outlook.

Original reporting
Published Nov 4, 2026, 12:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 12:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RYTHM Reports $23.9 Million in Q3 Revenue and $5.9 Million Adjusted EBITDA — source image
Decision brief

The 30-second read

$RYMNeutralMed
01

Why it matters

Earnings show incremental growth but continued losses; the market may view the adjusted EBITDA positively while remaining cautious about profitability.

02

Market read

Micro‑cap earnings with modest improvements; limited immediate trading impact but useful for sector monitoring.

03

What to watch

The recent stockholder amendment removing a beneficial ownership limit may enable future capital raises.

Relevance 6/10Novelty 7/10Timing: after-hours release

Background

RYTHM is a publicly traded company focused on THC-infused beverages, recently expanding its product line and retail presence.

Company-level read

Ticker impact

$RYMNeutralMedium confidence
Context

RYTHM reported Q3 2026 revenue of $23.9M, adjusted EBITDA of $5.9M, and net loss of $0.5M, providing the first public disclosure of these figures.

Expected impact

likely modest pressure as the market prices in the modest earnings beat and limited growth outlook

Evidence & confidence

Micro‑cap earnings often cause limited price movement; the numbers are better than loss but not enough to drive a strong rally.

Market effects

Provides a data point for the emerging THC beverage sector, indicating modest growth and expanding retail footprint.

Limited to U.S. markets where the company operates; no broader regional effect.

Low global relevance given the company's micro‑cap size and niche market.

Counterpoint

The positive adjusted EBITDA could be a catalyst for a short‑term bounce if investors overlook the net loss.

Key entities

  • RYTHM Inc.

    Issuer of the Q3 2026 earnings report.

Related articles

$RYMMed

RYTHM, Inc. Reports Third Quarter 2026 Results

RYTHM, Inc. (RYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 RYTHM, Inc. Reports Third Quarter 2026 Results ROLLING MEADOWS, IL, November 4, 2026 – RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company, whose portfolio of trusted THC brands includes RYTHM, Señorita, incredibles, Beboe, and Dogwalkers, tod

$GTBIFMed

Green Thumb Amends RYTHM Notes and Warrants, Removes Ownership Cap; $72M Notes Affected

Green Thumb Industries (GTBIF) amended its secured convertible notes, pre-funded warrants, and shared services agreement with RYTHM to remove a 49.99% beneficial ownership cap. The amendment affects $72.0M of original principal and warrants for up to 9,731,638 shares, effective Oct 10, 2026. Green Thumb will consolidate RYTHM from that date, without intending to exercise the securities.

$RYMMed

RYTHM, Inc. Reports Second Quarter 2026 Results

RYTHM, Inc. (RYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 RYTHM, Inc. Reports Second Quarter 2026 Results ROLLING MEADOWS, IL, August 4, 2026 (GLOBE NEWSWIRE) – RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company whose portfolio of trusted THC brands includes RYTHM, Señorita, incredibles, Beboe, and

$RYMMedAI 8/10

Daily NZX update, Friday, June 5, 2026

NZX 50 was up 0.3% at 3:00pm, though down 0.5% over five days and 2.6% over six months. Top gainers included Air New Zealand (+2%), Mainfreight (+2%) and Genesis Energy (+2%); biggest fallers were Kathmandu (-3%), A2 Milk (-2%) and Tourism Holdings (-2%). SmartShares ETFs were mixed. Meridian welcomed a draft Fast-track Panel decision on Lake Pūkaki access; Infratil completed a $200m capital bond offer; Ryman reported FY26 EBITDAF $88.3m and free cash flow $188.3m.

$RYMMedAI 8/10

Daily NZX update, Wednesday, June 3, 2026

NZX50 was down 0.3% at 3:00pm, though up 0.4% over five sessions and 6.5% over 12 months. Gentrack Group led gainers (+4%), while Vista Group fell the most (-3%). Ebos (-3%) and A2 Milk (-1%) also declined. Ryman Healthcare is considering new six-year secured bonds; Scales Corp declared a 12.5c FY2025 final dividend; Pacific Edge raised NZ$36.1m at NZ$0.17/share.